- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05565040
Concealed Penis in Pediatric Age Group
October 5, 2022 updated by: Ahmed Elrouby, Egyptian Biomedical Research Network
Concealed Penis in Pediatric Age Group; A Comparison Between Three Surgical Techniques
Background: Comparison between three different surgical techniques in the management of concealed penis.
Methods: This prospective interventional non-randomized study included 150 pediatric patients with concealed penis.
They were distributed equally into three groups; group A; patients treated by phallopexy only, group B; patients treated by complete dissection and excision of dartos fascia & group C; patients treated by both phallopexy and dartos excision.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Background: Comparison between three different surgical techniques in the management of concealed penis.
Methods: This prospective interventional non-randomized study included 150 pediatric patients with concealed penis.
They were distributed equally into three groups; group A; patients treated by anchoring the penile skin dermis to Buck's fascia at the penile base at 3 & 9 o'clock points using PDS 5/0 (phallopexy), group B; patients treated by complete dissection and excision of dartos fascia & group C; patients treated by phallopexy as in group A after complete dissection and excision of dartos fascia.
Follow-up at the end of the 1st post-operative week and then monthly for 6 months as regards penile skin congestion and/or necrosis, wound infection, edema, and/or re-retraction was carried out.
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt, 12345
- Faulty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- patients with a buried penis at or below the pubic skin level with a stretched penile length for all of them within the normal range according to their ages as titrated in the literature
Exclusion Criteria:
- Patients with any associated anomalies like hypospadias, torsion, penoscrotal web, micropenis, mega-prepuce, or chordae were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phallopexy group
phallopexy only
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
|
Experimental: Dartos excision group
complete circumferential dissection and excision of dartos fascia only
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
|
Experimental: Combined phallopexy and dartos excision group
phallopexy as in patients of group A but after complete dissection and excision of dartos fascia
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative appearance of penile skin congestion and/or necrosis
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards persistent bluish penile discoloration and or loss of penile skin viability.
Also a questionnaire of parents about penile skin color, loss of skin, and/or appearance of any abnormal tissues
|
6 months
|
|
Wound infection
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the appearance of any penile skin infection and/or pyogenic discharge.
Also a questionnaire of parents about the appearance of penile skin redness, pyogenic discharge, and/or the appearance of any pyogenic membranes
|
6 months
|
|
Penile edema
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the appearance of penile skin edema.
Also a questionnaire of parents about any increase of penile girth than the usual
|
6 months
|
|
Penile re-retraction
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the development of any penile re-retraction in the form of retraction of the penis to or beneath the level of pubic skin.
Also, a questionnaire of parents about this finding was done
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ahmed EZ Elrouby, A.Professor, University of Alexandria
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2018
Primary Completion (Actual)
June 1, 2021
Study Completion (Actual)
June 1, 2021
Study Registration Dates
First Submitted
September 21, 2022
First Submitted That Met QC Criteria
September 29, 2022
First Posted (Actual)
October 4, 2022
Study Record Updates
Last Update Posted (Actual)
October 7, 2022
Last Update Submitted That Met QC Criteria
October 5, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0305434
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urologic Diseases
-
University Hospital, ToulouseNot yet recruitingUrologic Cancer | Magnetic Resonance Imaging (MRI)France
-
The First Affiliated Hospital of Zhengzhou UniversityCompletedUrologic Cancer | Prostate | Robot Assisted Laparoscopic Radical ProstatectomyChina
-
University Hospital, GhentCompletedSurgery | Bladder Cancer | Urologic CancerBelgium
-
Chang Gung Memorial HospitalCompleted
-
Wuhan Union Hospital, ChinaRecruiting
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung... and other collaboratorsActive, not recruiting
-
Medical University of GrazRecruiting
-
Fundación Pública Andaluza para la gestión de la...RecruitingSurgery | Anesthesia | Urologic CancerSpain
-
IRCCS San RaffaeleRecruitingUrologic Diseases | Infertility | Urologic CancerItaly
-
Duke UniversityNational Cancer Institute (NCI)Not yet recruitingPelvic Cancer | Urologic Cancer | Gynecologic Cancers | Vaginal Stenosis | Pelvic Radiotherapy | Anorectal CancerUnited States
Clinical Trials on Circumcision in concealed penis
-
University of ThessalyRecruitingPhimosis | Foreskin; Tightness | Redundant PrepuceGreece
-
Feng PanCompleted
-
Istanbul UniversityCompletedPostoperative Analgesia
-
Adiyaman UniversityRecruitingCircumcision, Male | Circumcision | Circumcision AdultTurkey (Türkiye)